SNPS

Synopsys
D

SNPS

Arincen72/100B

Synopsys revenue 1990–2026

Synopsys's revenue in Q3 FY2026, the three months to 31 July 2026, was 2.48B USD, up 42.4% on the same quarter a year before. Synopsys's revenue over the last twelve months was 9.42B USD, up 46.3% on the twelve months before. In fiscal year 2025 it was 7.05B USD, up 15.1% on the year before.

Last updated 6 Nov 2026 · Next report 8 Dec 2026

Revenue

Growth

Fiscal yearPeriod endingRevenueGrowthGross profitNet income
TTM31 Jul 20269.42B+46.33%6.82B1.08B
FY202531 Oct 20257.05B+15.12%5.43B1.33B
FY202431 Oct 20246.13B+15.22%4.88B2.26B
FY202331 Oct 20235.32B+15.22%4.29B1.23B
FY202231 Oct 20224.62B+9.79%3.72B984.59M
FY202131 Oct 20214.20B+14.08%3.34B757.52M
FY202031 Oct 20203.69B+9.66%2.89B664.35M
FY201931 Oct 20193.36B+7.68%2.61B532.37M
FY201831 Oct 20183.12B+14.54%2.39B432.52M
FY201731 Oct 20172.72B+12.48%2.07B136.56M
FY201631 Oct 20162.42B+8.04%1.88B266.83M
FY201531 Oct 20152.24B+8.98%1.72B225.93M
FY201431 Oct 20142.06B+4.85%1.60B259.12M
FY201331 Oct 20131.96B+11.74%1.51B247.80M
FY201231 Oct 20121.76B+14.35%1.36B182.40M
FY201131 Oct 20111.54B+11.23%1.20B221.36M
FY201031 Oct 20101.38B+1.52%1.10B237.06M
FY200931 Oct 20091.36B+1.73%1.09B167.68M
FY200831 Oct 20081.34B+10.27%1.08B189.98M
FY200731 Oct 20071.21B+10.67%978.20M130.49M
FY200631 Oct 20061.10B+10.45%872.03M24.74M
FY200531 Oct 2005991.93M-9.17%737.30M-15.48M
FY200431 Oct 20041.09B-7.21%937.62M74.34M
FY200331 Oct 20031.18B+29.83%1.03B149.72M
FY200231 Oct 2002906.53M+33.25%733.38M-199.99M
FY200131 Oct 2001680.35M-13.20%550.23M56.80M
FY200031 Oct 2000783.78M-2.77%707.95M97.78M
FY199930 Sept 1999806.10M+12.29%743.40M161.40M
FY199830 Sept 1998717.90M+10.96%668.30M91.70M
FY199730 Sept 1997647.00M+23.10%599.90M72.40M
FY199630 Sept 1996525.60M+97.97%489.00M23.70M
FY199530 Sept 1995265.50M+35.46%250.40M30.30M
FY199430 Sept 1994196.00M+81.48%181.60M15.80M
FY199330 Sept 1993108.00M+71.43%99.50M13.20M
FY199230 Sept 199263.00M+55.56%57.00M7.10M
FY199130 Sept 199140.50M+83.26%36.80M3.50M
FY199030 Sept 199022.10M—20.30M4.00M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

Synopsys revenue growth by segment

Q3 FY2026 against Q3 FY2025

License and Maintenance1.00B
+12.4%
Technology Service808.81M
+144.4%
License665.22M
+28.8%

Synopsys revenue by segment over time

License and Maintenance License Technology Service Product
Fiscal yearLicense and MaintenanceLicenseTechnology ServiceProduct
FY20253.49B +8.2%2.01B +11.6%1.55B +41.2%—
FY20243.22B -4.7%1.80B +26.1%1.10B +6.9%—
FY20233.38B +13.0%1.43B +16.5%1.03B +19.6%4.81B +14.0%
FY20222.99B +13.7%1.23B +42.5%861.03M +21.4%4.22B
FY20212.63B +11.4%861.06M +17.1%709.37M +21.4%—
FY20202.37B +7.6%735.57M +18.7%584.51M +7.7%—
FY20192.20B -4.6%619.79M +73.3%542.94M +18.0%—
FY20182.30B 357.70M 460.04M —

See also:Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about Synopsys's revenue

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.